 | • レポートコード：D005-11677 • 出版社/出版日：GlobalInfoResearch / 2020年5月28日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、136ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、OTC医薬品の世界市場を広く調査・分析し、今後の市場展望をまとめております。OTC医薬品の種類別市場規模（クラスA、クラスB）、用途別市場規模（病院、クリニック、家庭）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Bayer HealthCare、Bristol Myers Squibb、Pfizer、GlaxoSmithKline (GSK)、BioGaia、Johnson&Johnson、Chr. Hansen、AstraZeneca、Sanofi、Bukwang Pharmaceutica、DSM、Herbalife、Cipla、Eisai、Friggs、CoLucid、Euradite、Eli Lilly、Daiichi Sankyo ・地域別グローバル市場分析 2015年-2020年 ・OTC医薬品の北米市場（アメリカ、カナダ、メキシコ） ・OTC医薬品のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・OTC医薬品のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・OTC医薬品の南米市場（ブラジル、アルゼンチン） ・OTC医薬品の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：クラスA、クラスB ・用途別分析：病院、クリニック、家庭 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global OTC Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The OTC Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
OTC Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, OTC Drug market has been segmented into
Class A
Class B
By Application, OTC Drug has been segmented into:
Hospital
Clinic
Household
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global OTC Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level OTC Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global OTC Drug market.
The report offers in-depth assessment of the growth and other aspects of the OTC Drug market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and OTC Drug Market Share Analysis
OTC Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, OTC Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the OTC Drug sales, revenue and market share for each player covered in this report.
The major players covered in OTC Drug are:
Bayer HealthCare
Bristol Myers Squibb
Pfizer
GlaxoSmithKline (GSK)
BioGaia
Johnson&Johnson
Chr. Hansen
AstraZeneca
Sanofi
Bukwang Pharmaceutica
DSM
Herbalife
Cipla
Eisai
Friggs
CoLucid
Euradite
Eli Lilly
Daiichi Sankyo
Among other players domestic and global, OTC Drug market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe OTC Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of OTC Drug, with price, sales, revenue and global market share of OTC Drug in 2018 and 2019.
Chapter 3, the OTC Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the OTC Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, OTC Drug market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe OTC Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 OTC Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global OTC Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Class A
1.2.3 Class B
1.3 Market Analysis by Application
1.3.1 Overview: Global OTC Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Household
1.4 Overview of Global OTC Drug Market
1.4.1 Global OTC Drug Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Bayer HealthCare
2.1.1 Bayer HealthCare Details
2.1.2 Bayer HealthCare Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Bayer HealthCare SWOT Analysis
2.1.4 Bayer HealthCare Product and Services
2.1.5 Bayer HealthCare OTC Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Bristol Myers Squibb
2.2.1 Bristol Myers Squibb Details
2.2.2 Bristol Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Bristol Myers Squibb SWOT Analysis
2.2.4 Bristol Myers Squibb Product and Services
2.2.5 Bristol Myers Squibb OTC Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Pfizer SWOT Analysis
2.3.4 Pfizer Product and Services
2.3.5 Pfizer OTC Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 GlaxoSmithKline (GSK)
2.4.1 GlaxoSmithKline (GSK) Details
2.4.2 GlaxoSmithKline (GSK) Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 GlaxoSmithKline (GSK) SWOT Analysis
2.4.4 GlaxoSmithKline (GSK) Product and Services
2.4.5 GlaxoSmithKline (GSK) OTC Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 BioGaia
2.5.1 BioGaia Details
2.5.2 BioGaia Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 BioGaia SWOT Analysis
2.5.4 BioGaia Product and Services
2.5.5 BioGaia OTC Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Johnson&Johnson
2.6.1 Johnson&Johnson Details
2.6.2 Johnson&Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Johnson&Johnson SWOT Analysis
2.6.4 Johnson&Johnson Product and Services
2.6.5 Johnson&Johnson OTC Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Chr. Hansen
2.7.1 Chr. Hansen Details
2.7.2 Chr. Hansen Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Chr. Hansen SWOT Analysis
2.7.4 Chr. Hansen Product and Services
2.7.5 Chr. Hansen OTC Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 AstraZeneca
2.8.1 AstraZeneca Details
2.8.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 AstraZeneca SWOT Analysis
2.8.4 AstraZeneca Product and Services
2.8.5 AstraZeneca OTC Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Sanofi
2.9.1 Sanofi Details
2.9.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Sanofi SWOT Analysis
2.9.4 Sanofi Product and Services
2.9.5 Sanofi OTC Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Bukwang Pharmaceutica
2.10.1 Bukwang Pharmaceutica Details
2.10.2 Bukwang Pharmaceutica Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Bukwang Pharmaceutica SWOT Analysis
2.10.4 Bukwang Pharmaceutica Product and Services
2.10.5 Bukwang Pharmaceutica OTC Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 DSM
2.11.1 DSM Details
2.11.2 DSM Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 DSM SWOT Analysis
2.11.4 DSM Product and Services
2.11.5 DSM OTC Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Herbalife
2.12.1 Herbalife Details
2.12.2 Herbalife Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Herbalife SWOT Analysis
2.12.4 Herbalife Product and Services
2.12.5 Herbalife OTC Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Cipla
2.13.1 Cipla Details
2.13.2 Cipla Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Cipla SWOT Analysis
2.13.4 Cipla Product and Services
2.13.5 Cipla OTC Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Eisai
2.14.1 Eisai Details
2.14.2 Eisai Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Eisai SWOT Analysis
2.14.4 Eisai Product and Services
2.14.5 Eisai OTC Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Friggs
2.15.1 Friggs Details
2.15.2 Friggs Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Friggs SWOT Analysis
2.15.4 Friggs Product and Services
2.15.5 Friggs OTC Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 CoLucid
2.16.1 CoLucid Details
2.16.2 CoLucid Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 CoLucid SWOT Analysis
2.16.4 CoLucid Product and Services
2.16.5 CoLucid OTC Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.17 Euradite
2.17.1 Euradite Details
2.17.2 Euradite Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Euradite SWOT Analysis
2.17.4 Euradite Product and Services
2.17.5 Euradite OTC Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.18 Eli Lilly
2.18.1 Eli Lilly Details
2.18.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Eli Lilly SWOT Analysis
2.18.4 Eli Lilly Product and Services
2.18.5 Eli Lilly OTC Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.19 Daiichi Sankyo
2.19.1 Daiichi Sankyo Details
2.19.2 Daiichi Sankyo Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 Daiichi Sankyo SWOT Analysis
2.19.4 Daiichi Sankyo Product and Services
2.19.5 Daiichi Sankyo OTC Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global OTC Drug Sales and Market Share by Manufacturer (2018-2019)
3.2 Global OTC Drug Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 OTC Drug Manufacturer Market Share in 2019
3.3.2 Top 6 OTC Drug Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global OTC Drug Sales, Revenue and Market Share by Regions
4.1.1 Global OTC Drug Sales and Market Share by Regions (2015-2020)
4.1.2 Global OTC Drug Revenue and Market Share by Regions (2015-2020)
4.2 North America OTC Drug Sales and Growth Rate (2015-2020)
4.3 Europe OTC Drug Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific OTC Drug Sales and Growth Rate (2015-2020)
4.5 South America OTC Drug Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa OTC Drug Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America OTC Drug Sales, Revenue and Market Share by Country
5.1.1 North America OTC Drug Sales and Market Share by Country (2015-2020)
5.1.2 North America OTC Drug Revenue and Market Share by Country (2015-2020)
5.2 United States OTC Drug Sales and Growth Rate (2015-2020)
5.3 Canada OTC Drug Sales and Growth Rate (2015-2020)
5.4 Mexico OTC Drug Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe OTC Drug Sales, Revenue and Market Share by Country
6.1.1 Europe OTC Drug Sales and Market Share by Country (2015-2020)
6.1.2 Europe OTC Drug Revenue and Market Share by Country (2015-2020)
6.2 Germany OTC Drug Sales and Growth Rate (2015-2020)
6.3 UK OTC Drug Sales and Growth Rate (2015-2020)
6.4 France OTC Drug Sales and Growth Rate (2015-2020)
6.5 Russia OTC Drug Sales and Growth Rate (2015-2020)
6.6 Italy OTC Drug Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific OTC Drug Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific OTC Drug Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific OTC Drug Revenue and Market Share by Regions (2015-2020)
7.2 China OTC Drug Sales and Growth Rate (2015-2020)
7.3 Japan OTC Drug Sales and Growth Rate (2015-2020)
7.4 Korea OTC Drug Sales and Growth Rate (2015-2020)
7.5 India OTC Drug Sales and Growth Rate (2015-2020)
7.6 Southeast Asia OTC Drug Sales and Growth Rate (2015-2020)
7.7 Australia OTC Drug Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America OTC Drug Sales, Revenue and Market Share by Country
8.1.1 South America OTC Drug Sales and Market Share by Country (2015-2020)
8.1.2 South America OTC Drug Revenue and Market Share by Country (2015-2020)
8.2 Brazil OTC Drug Sales and Growth Rate (2015-2020)
8.3 Argentina OTC Drug Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa OTC Drug Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa OTC Drug Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa OTC Drug Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia OTC Drug Sales and Growth Rate (2015-2020)
9.3 Turkey OTC Drug Sales and Growth Rate (2015-2020)
9.4 Egypt OTC Drug Sales and Growth Rate (2015-2020)
9.5 South Africa OTC Drug Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global OTC Drug Sales and Market Share by Type (2015-2020)
10.2 Global OTC Drug Revenue and Market Share by Type (2015-2020)
10.3 Global OTC Drug Price by Type (2015-2020)
11 Global OTC Drug Market Segment by Application
11.1 Global OTC Drug Sales Market Share by Application (2015-2020)
11.2 Global OTC Drug Revenue Market Share by Application (2015-2020)
11.3 Global OTC Drug Price by Application (2015-2020)
12 Market Forecast
12.1 Global OTC Drug Sales, Revenue and Growth Rate (2021-2025)
12.2 OTC Drug Market Forecast by Regions (2021-2025)
12.2.1 North America OTC Drug Market Forecast (2021-2025)
12.2.2 Europe OTC Drug Market Forecast (2021-2025)
12.2.3 Asia-Pacific OTC Drug Market Forecast (2021-2025)
12.2.4 South America OTC Drug Market Forecast (2021-2025)
12.2.5 Middle East & Africa OTC Drug Market Forecast (2021-2025)
12.3 OTC Drug Market Forecast by Type (2021-2025)
12.3.1 Global OTC Drug Sales Forecast by Type (2021-2025)
12.3.2 Global OTC Drug Market Share Forecast by Type (2021-2025)
12.4 OTC Drug Market Forecast by Application (2021-2025)
12.4.1 Global OTC Drug Sales Forecast by Application (2021-2025)
12.4.2 Global OTC Drug Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global OTC Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of OTC Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global OTC Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Bayer HealthCare Basic Information, Manufacturing Base and Competitors
Table 8. Bayer HealthCare OTC Drug Major Business
Table 9. Bayer HealthCare OTC Drug Total Revenue (USD Million) (2018-2019)
Table 10. Bayer HealthCare SWOT Analysis
Table 11. Bayer HealthCare OTC Drug Product and Services
Table 12. Bayer HealthCare OTC Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Bristol Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 14. Bristol Myers Squibb OTC Drug Major Business
Table 15. Bristol Myers Squibb OTC Drug Total Revenue (USD Million) (2018-2019)
Table 16. Bristol Myers Squibb SWOT Analysis
Table 17. Bristol Myers Squibb OTC Drug Product and Services
Table 18. Bristol Myers Squibb OTC Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Pfizer Basic Information, Manufacturing Base and Competitors
Table 20. Pfizer OTC Drug Major Business
Table 21. Pfizer OTC Drug Total Revenue (USD Million) (2018-2019)
Table 22. Pfizer SWOT Analysis
Table 23. Pfizer OTC Drug Product and Services
Table 24. Pfizer OTC Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. GlaxoSmithKline (GSK) Basic Information, Manufacturing Base and Competitors
Table 26. GlaxoSmithKline (GSK) OTC Drug Major Business
Table 27. GlaxoSmithKline (GSK) OTC Drug Total Revenue (USD Million) (2018-2019)
Table 28. GlaxoSmithKline (GSK) SWOT Analysis
Table 29. GlaxoSmithKline (GSK) OTC Drug Product and Services
Table 30. GlaxoSmithKline (GSK) OTC Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. BioGaia Basic Information, Manufacturing Base and Competitors
Table 32. BioGaia OTC Drug Major Business
Table 33. BioGaia OTC Drug Total Revenue (USD Million) (2018-2019)
Table 34. BioGaia SWOT Analysis
Table 35. BioGaia OTC Drug Product and Services
Table 36. BioGaia OTC Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Johnson&Johnson Basic Information, Manufacturing Base and Competitors
Table 38. Johnson&Johnson OTC Drug Major Business
Table 39. Johnson&Johnson OTC Drug Total Revenue (USD Million) (2018-2019)
Table 40. Johnson&Johnson SWOT Analysis
Table 41. Johnson&Johnson OTC Drug Product and Services
Table 42. Johnson&Johnson OTC Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Chr. Hansen Basic Information, Manufacturing Base and Competitors
Table 44. Chr. Hansen OTC Drug Major Business
Table 45. Chr. Hansen OTC Drug Total Revenue (USD Million) (2018-2019)
Table 46. Chr. Hansen SWOT Analysis
Table 47. Chr. Hansen OTC Drug Product and Services
Table 48. Chr. Hansen OTC Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 50. AstraZeneca OTC Drug Major Business
Table 51. AstraZeneca OTC Drug Total Revenue (USD Million) (2018-2019)
Table 52. AstraZeneca SWOT Analysis
Table 53. AstraZeneca OTC Drug Product and Services
Table 54. AstraZeneca OTC Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Sanofi Basic Information, Manufacturing Base and Competitors
Table 56. Sanofi OTC Drug Major Business
Table 57. Sanofi OTC Drug Total Revenue (USD Million) (2018-2019)
Table 58. Sanofi SWOT Analysis
Table 59. Sanofi OTC Drug Product and Services
Table 60. Sanofi OTC Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Bukwang Pharmaceutica Basic Information, Manufacturing Base and Competitors
Table 62. Bukwang Pharmaceutica OTC Drug Major Business
Table 63. Bukwang Pharmaceutica OTC Drug Total Revenue (USD Million) (2018-2019)
Table 64. Bukwang Pharmaceutica SWOT Analysis
Table 65. Bukwang Pharmaceutica OTC Drug Product and Services
Table 66. Bukwang Pharmaceutica OTC Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. DSM Basic Information, Manufacturing Base and Competitors
Table 68. DSM OTC Drug Major Business
Table 69. DSM OTC Drug Total Revenue (USD Million) (2018-2019)
Table 70. DSM SWOT Analysis
Table 71. DSM OTC Drug Product and Services
Table 72. DSM OTC Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Herbalife Basic Information, Manufacturing Base and Competitors
Table 74. Herbalife OTC Drug Major Business
Table 75. Herbalife OTC Drug Total Revenue (USD Million) (2018-2019)
Table 76. Herbalife SWOT Analysis
Table 77. Herbalife OTC Drug Product and Services
Table 78. Herbalife OTC Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Cipla Basic Information, Manufacturing Base and Competitors
Table 80. Cipla OTC Drug Major Business
Table 81. Cipla OTC Drug Total Revenue (USD Million) (2018-2019)
Table 82. Cipla SWOT Analysis
Table 83. Cipla OTC Drug Product and Services
Table 84. Cipla OTC Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Eisai Basic Information, Manufacturing Base and Competitors
Table 86. Eisai OTC Drug Major Business
Table 87. Eisai OTC Drug Total Revenue (USD Million) (2018-2019)
Table 88. Eisai SWOT Analysis
Table 89. Eisai OTC Drug Product and Services
Table 90. Eisai OTC Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. Friggs Basic Information, Manufacturing Base and Competitors
Table 92. Friggs OTC Drug Major Business
Table 93. Friggs OTC Drug Total Revenue (USD Million) (2018-2019)
Table 94. Friggs SWOT Analysis
Table 95. Friggs OTC Drug Product and Services
Table 96. Friggs OTC Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 97. CoLucid Basic Information, Manufacturing Base and Competitors
Table 98. CoLucid OTC Drug Major Business
Table 99. CoLucid OTC Drug Total Revenue (USD Million) (2018-2019)
Table 100. CoLucid SWOT Analysis
Table 101. CoLucid OTC Drug Product and Services
Table 102. CoLucid OTC Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 103. Euradite Basic Information, Manufacturing Base and Competitors
Table 104. Euradite OTC Drug Major Business
Table 105. Euradite OTC Drug Total Revenue (USD Million) (2018-2019)
Table 106. Euradite SWOT Analysis
Table 107. Euradite OTC Drug Product and Services
Table 108. Euradite OTC Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 109. Eli Lilly OTC Drug Type and Application
Table 110. Eli Lilly OTC Drug Major Business
Table 111. Eli Lilly OTC Drug Total Revenue (USD Million) (2018-2019)
Table 112. Eli Lilly SWOT Analysis
Table 113. Eli Lilly OTC Drug Product and Services
Table 114. Eli Lilly OTC Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 115. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table 116. Daiichi Sankyo OTC Drug Major Business
Table 117. Daiichi Sankyo OTC Drug Total Revenue (USD Million) (2018-2019)
Table 118. Daiichi Sankyo SWOT Analysis
Table 119. Daiichi Sankyo OTC Drug Product and Services
Table 120. Daiichi Sankyo OTC Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 121. Global OTC Drug Sales by Manufacturer (2018-2019) (K MT)
Table 122. Global OTC Drug Revenue by Manufacturer (2018-2019) (USD Million)
Table 123. Global OTC Drug Sales by Regions (2015-2020) (K MT)
Table 124. Global OTC Drug Sales Market Share by Regions (2015-2020)
Table 125. Global OTC Drug Revenue by Regions (2015-2020) (USD Million)
Table 126. North America OTC Drug Sales by Countries (2015-2020) (K MT)
Table 127. North America OTC Drug Sales Market Share by Countries (2015-2020)
Table 128. North America OTC Drug Revenue by Countries (2015-2020) (USD Million)
Table 129. North America OTC Drug Revenue Market Share by Countries (2015-2020)
Table 130. Europe OTC Drug Sales by Countries (2015-2020) (K MT)
Table 131. Europe OTC Drug Sales Market Share by Countries (2015-2020)
Table 132. Europe OTC Drug Revenue by Countries (2015-2020) (USD Million)
Table 133. Asia-Pacific OTC Drug Sales by Regions (2015-2020) (K MT)
Table 134. Asia-Pacific OTC Drug Sales Market Share by Regions (2015-2020)
Table 135. Asia-Pacific OTC Drug Revenue by Regions (2015-2020) (USD Million)
Table 136. South America OTC Drug Sales by Countries (2015-2020) (K MT)
Table 137. South America OTC Drug Sales Market Share by Countries (2015-2020)
Table 138. South America OTC Drug Revenue by Countries (2015-2020) (USD Million)
Table 139. South America OTC Drug Revenue Market Share by Countries (2015-2020)
Table 140. Middle East & Africa OTC Drug Sales by Countries (2015-2020) (K MT)
Table 141. Middle East & Africa OTC Drug Sales Market Share by Countries (2015-2020)
Table 142. Middle East & Africa OTC Drug Revenue by Countries (2015-2020) (USD Million)
Table 143. Middle East & Africa OTC Drug Revenue Market Share by Countries (2015-2020)
Table 144. Global OTC Drug Sales by Type (2015-2020) (K MT)
Table 145. Global OTC Drug Sales Share by Type (2015-2020)
Table 146. Global OTC Drug Revenue by Type (2015-2020) (USD Million)
Table 147. Global OTC Drug Revenue Share by Type (2015-2020)
Table 148. Global OTC Drug Sales by Application (2015-2020) (K MT)
Table 149. Global OTC Drug Sales Share by Application (2015-2020)
Table 150. Global OTC Drug Sales Forecast by Regions (2021-2025) (K MT)
Table 151. Global OTC Drug Market Share Forecast by Regions (2021-2025)
Table 152. Global OTC Drug Sales Forecast by Type (2021-2025) (K MT)
Table 153. Global OTC Drug Market Share Forecast by Type (2021-2025)
Table 154. Global OTC Drug Sales Forecast by Application (2021-2025)
Table 155. Global OTC Drug Market Share Forecast by Application (2021-2025)
Table 156. Direct Channel Pros & Cons
Table 157. Indirect Channel Pros & Cons
Table 158. Distributors/Traders/ Dealers List
List of Figures
Figure 1. OTC Drug Picture
Figure 2. Global Sales Market Share of OTC Drug by Type in 2019
Figure 3. Class A Picture
Figure 4. Class B Picture
Figure 5. OTC Drug Sales Market Share by Application in 2018
Figure 6. Hospital Picture
Figure 7. Clinic Picture
Figure 8. Household Picture
Figure 9. Global OTC Drug Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States OTC Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada OTC Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico OTC Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany OTC Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France OTC Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK OTC Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia OTC Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy OTC Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China OTC Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan OTC Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea OTC Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India OTC Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia OTC Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia OTC Drug Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil OTC Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt OTC Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia OTC Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa OTC Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey OTC Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global OTC Drug Sales Market Share by Manufacturer in 2019
Figure 30. Global OTC Drug Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 OTC Drug Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 OTC Drug Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global OTC Drug Sales and Growth Rate (2015-2020) (K MT)
Figure 35. Global OTC Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global OTC Drug Revenue Market Share by Regions (2015-2020)
Figure 37. Global OTC Drug Revenue Market Share by Regions in 2018
Figure 38. North America OTC Drug Sales and Growth Rate (2015-2020)
Figure 39. Europe OTC Drug Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific OTC Drug Sales and Growth Rate (2015-2020)
Figure 41. South America OTC Drug Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa OTC Drug Sales and Growth Rate (2015-2020)
Figure 43. North America OTC Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America OTC Drug Sales Market Share by Countries (2015-2020)
Figure 45. North America OTC Drug Sales Market Share by Countries in 2018
Figure 46. North America OTC Drug Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America OTC Drug Revenue Market Share by Countries in 2018
Figure 48. United States OTC Drug Sales and Growth Rate (2015-2020) (K MT)
Figure 49. Canada OTC Drug Sales and Growth Rate (2015-2020) (K MT)
Figure 50. Mexico OTC Drug Sales and Growth Rate (2015-2020) (K MT)
Figure 51. Europe OTC Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe OTC Drug Revenue Market Share by Countries (2015-2020)
Figure 53. Europe OTC Drug Revenue Market Share by Countries in 2019
Figure 54. Germany OTC Drug Sales and Growth Rate (2015-2020) (K MT)
Figure 55. UK OTC Drug Sales and Growth Rate (2015-2020) (K MT)
Figure 56. France OTC Drug Sales and Growth Rate (2015-2020) (K MT)
Figure 57. Russia OTC Drug Sales and Growth Rate (2015-2020) (K MT)
Figure 58. Italy OTC Drug Sales and Growth Rate (2015-2020) (K MT)
Figure 59. Asia-Pacific OTC Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific OTC Drug Sales Market Share by Regions 2019
Figure 61. Asia-Pacific OTC Drug Revenue Market Share by Regions 2019
Figure 62. China OTC Drug Sales and Growth Rate (2015-2020) (K MT)
Figure 63. Japan OTC Drug Sales and Growth Rate (2015-2020) (K MT)
Figure 64. Korea OTC Drug Sales and Growth Rate (2015-2020) (K MT)
Figure 65. India OTC Drug Sales and Growth Rate (2015-2020) (K MT)
Figure 66. Southeast Asia OTC Drug Sales and Growth Rate (2015-2020) (K MT)
Figure 67. South America OTC Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America OTC Drug Sales Market Share by Countries in 2019
Figure 69. South America OTC Drug Revenue Market Share by Countries in 2019
Figure 70. Brazil OTC Drug Sales and Growth Rate (2015-2020) (K MT)
Figure 71. Argentina OTC Drug Sales and Growth Rate (2015-2020) (K MT)
Figure 72. Middle East and Africa OTC Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa OTC Drug Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa OTC Drug Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa OTC Drug Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia OTC Drug Sales and Growth Rate (2015-2020) (K MT)
Figure 77. Egypt OTC Drug Sales and Growth Rate (2015-2020) (K MT)
Figure 78. Turkey OTC Drug Sales and Growth Rate (2015-2020) (K MT)
Figure 79. South Africa OTC Drug Sales and Growth Rate (2015-2020) (K MT)
Figure 80. Global OTC Drug Sales and Growth Rate (2021-2025) (K MT)
Figure 81. Global OTC Drug Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales OTC Drug Market Forecast (2021-2025) (K MT)
Figure 83. Europe Sales OTC Drug Market Forecast (2021-2025) (K MT)
Figure 84. Asia-Pacific Sales OTC Drug Market Forecast (2021-2025) (K MT)
Figure 85. South America Sales OTC Drug Market Forecast (2021-2025) (K MT)
Figure 86. Middle East & Africa Sales OTC Drug Market Forecast (2021-2025) (K MT)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel
アレルギー鼻炎薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Allergy Rhinitis Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Allergy Rhinitis Drug m…- 内分泌系薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Endocrine System Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Endocrine System Drug m…
- 消化器系薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Digestive System Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Digestive System Drug m…
- 特発性肺線維症薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Idiopathic Pulmonary Fibrosis Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Idiopathic…
- 植物薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Botanical Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Botanical Drug market report p…